Hours worked
17500 +
Protocols involved
20 +
Sponsors secured
10 +
We invite patients with seropositive rheumatoid arthritis of moderate or high degree of disease activity and insufficient response to methotrexate monotherapy to participate in a clinical trial of a new form of tocilizumab
Recruitment for a clinical trial of a new Russian HIB vaccine for children from 3 to 6 months has begun. The comparison drug is Pentaxime, the placebo group is not assumed. All examination and supervision of a pediatrician is free of charge.
Successfully passed a selection visit to participate in a clinical research of a new medicine for the treatment of erosive form of gastroesophageal reflux disease